Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.

被引：0
|
作者：
Verma, SK
Reddy, S
Nagarathnam, D
Shao, JX
Zhang, L
Zhao, J
Wang, YM
Li, T
Mull, E
Wang, CG
Zhu, QM
Altieri, M
Dang, TTA
Jordan, J
机构：
[1] Bayer Pharmaceut, Dept Chem, West Haven, CT 06516 USA
[2] Bayer Pharmaceut, Dept Canc Res, West Haven, CT USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
232-MEDI
引用
收藏
页码：U949 / U949
页数：1
相关论文
共 50 条
  • [41] ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITORS IN THE DEVELOPMENT OF CANCER
    HIRAMA, T
    KOEFFLER, HP
    [J]. BLOOD, 1995, 86 (03) : 841 - 854
  • [42] Cyclin-dependent kinase inhibitors: novel anticancer agents
    Mani, S
    Wang, CG
    Wu, KM
    Francis, R
    Pestell, R
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (08) : 1849 - 1870
  • [43] Cyclin-dependent kinase inhibitors move into Phase III
    Guha, Malini
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (12) : 892 - 894
  • [44] Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies
    Baghdassarian, N
    Ffrench, M
    [J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 (04): : 313 - 323
  • [45] Cyclin-dependent kinase 7 inhibitors in cancer therapy
    Wang, Minmin
    Wang, Tianyu
    Zhang, Xiangyu
    Wu, Xiaoxing
    Jiang, Sheng
    [J]. FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 813 - 833
  • [46] Cyclin-dependent kinase inhibitors for the treatment of lung cancer
    Qin, Angel
    Reddy, Haritha G.
    Weinberg, Frank D.
    Kalemkerian, Gregory P.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (08) : 941 - 952
  • [47] Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3
    Yue, EW
    DiMeo, SV
    Higley, CA
    Markwalder, JA
    Burton, CR
    Benfield, PA
    Grafstrom, RH
    Cox, S
    Muckelbauer, JK
    Smallwood, AM
    Chen, HY
    Chang, CH
    Trainor, GL
    Seitz, SP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) : 343 - 346
  • [48] Inhibitors of the Cyclin-Dependent Kinase and PIM Kinase Pathways in the Treatment of Myeloma
    Ramakrishnan, Vijay G.
    Kumar, Shaji K.
    [J]. CANCER JOURNAL, 2016, 22 (01): : 7 - 11
  • [49] PRECLINICAL AND CLINICAL DEVELOPMENT OF CYCLIN-DEPENDENT KINASE AND CHECKPOINT KINASE INHIBITORS
    Shapiro, G. I.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 27 - 27
  • [50] Synthesis and biological evaluations of pyrazolo[3,4-d] pyrimidines as cyclin-dependent kinase 2 inhibitors
    Kim, DC
    Lee, YR
    Yang, BS
    Shin, KJ
    Kim, DJ
    Chung, BY
    Yoo, KH
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (05) : 525 - 532
12345